CONTI, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 143
EU - Europa 118
NA - Nord America 102
SA - Sud America 44
AF - Africa 4
OC - Oceania 2
Totale 413
Nazione #
US - Stati Uniti d'America 98
SG - Singapore 61
RU - Federazione Russa 60
BR - Brasile 40
CN - Cina 35
HK - Hong Kong 17
IT - Italia 13
VN - Vietnam 10
DE - Germania 9
GB - Regno Unito 9
IE - Irlanda 9
FR - Francia 7
KR - Corea 6
SE - Svezia 6
JP - Giappone 4
AE - Emirati Arabi Uniti 2
AU - Australia 2
CO - Colombia 2
FI - Finlandia 2
GE - Georgia 2
ID - Indonesia 2
MX - Messico 2
ZA - Sudafrica 2
AR - Argentina 1
BD - Bangladesh 1
CA - Canada 1
ES - Italia 1
IN - India 1
JM - Giamaica 1
MA - Marocco 1
MK - Macedonia 1
NL - Olanda 1
TG - Togo 1
TR - Turchia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 413
Città #
Singapore 23
Hong Kong 17
Moscow 16
Ashburn 11
Dallas 11
Chandler 10
Dublin 9
Beijing 7
Falkenstein 4
Falls Church 4
Los Angeles 4
Sindelfingen 4
São Paulo 4
Ho Chi Minh City 3
Jacksonville 3
Mestrino 3
Milan 3
Redondo Beach 3
Rio de Janeiro 3
Shimotsuke 3
Southend 3
Tianjin 3
Chicago 2
Guangzhou 2
Helsinki 2
Houston 2
Jakarta 2
Kent 2
Lawrence 2
New York 2
Porto Alegre 2
Princeton 2
Santa Clara 2
Seattle 2
Southport 2
Spoleto 2
Sydney 2
Tbilisi 2
Verona 2
Wilmington 2
Zhengzhou 2
Americana 1
Araçatuba 1
Belo Horizonte 1
Beni Mellal 1
Betim 1
Blumenau 1
Boksburg 1
Brownsville 1
Brunswick 1
Buffalo 1
Buritama 1
Cabo de Santo Agostinho 1
Camaçari 1
Campinas 1
Campo Grande 1
Can Tho 1
Canindé 1
Caruaru 1
Chennai 1
City of London 1
Concord 1
Congonhas 1
Da Nang 1
Dhaka 1
Dongguan 1
Dubai 1
Elk Grove Village 1
Essen 1
Fortim 1
Fremont 1
Funabashi 1
Guarulhos 1
Haiphong 1
Harbin 1
Istanbul 1
Jaguarão 1
Jaraguá 1
Johannesburg 1
Joinville 1
João Pessoa 1
Kingston 1
Las Heras 1
Linhares 1
Lomé 1
London 1
Madrid 1
Maicao 1
Maldonado 1
Maringá 1
Medellín 1
Mexico City 1
Monterrey 1
Morada Nova 1
Nanjing 1
Natal 1
Niterói 1
Putian 1
Redmond 1
Redwood City 1
Totale 248
Nome #
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 112
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis 61
Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis 56
Management of long-term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting 55
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience 50
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement 50
Validation and Field Performance of the Italian Version of the Psoriatic Arthritis Screening and Evaluation (PASE) Questionnaire 37
Totale 421
Categoria #
all - tutte 2.003
article - articoli 2.003
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.006


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 1 1 1 0 0 0 1 0
2021/20226 0 0 0 0 1 0 0 1 2 0 0 2
2022/202343 3 2 3 6 6 7 0 1 8 0 7 0
2023/202458 3 7 8 8 6 4 4 3 0 0 11 4
2024/2025139 7 5 1 25 5 10 9 5 20 20 12 20
2025/2026150 28 16 26 78 2 0 0 0 0 0 0 0
Totale 421